Nov 6 |
Ovid Therapeutics Inc (OVID) Reports Q3 2023 Financial Results
|
Nov 3 |
Ovid Therapeutics reports Q3 results
|
Nov 3 |
Ovid Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Updates
|
Oct 29 |
We're Not Very Worried About Ovid Therapeutics' (NASDAQ:OVID) Cash Burn Rate
|
Oct 19 |
These 2 ‘Strong Buy’ Penny Stocks Have Massive Upside Potential, Says Oppenheimer
|
Oct 18 |
Ligand Pharmaceuticals acquires 13% of soticlestat royalties from Ovid Therapeutics for $30M
|
Oct 18 |
Ovid Therapeutics and Ligand Pharmaceuticals Enter into a $30 Million Agreement for a 13% Interest in Soticlestat Royalties and Milestones Extending Ovid’s Cash Runway into 2026
|
Oct 10 |
Ovid Therapeutics to Present at the Jefferies Biotech CNS/Neuro Summit
|
Oct 4 |
Ovid Therapeutics: The GABA Gambit In Seizure Wars
|
Sep 29 |
20 Countries With Highest Rate of Epilepsy
|